Page last updated: 2024-10-24

camostat and Colonic Neoplasms

camostat has been researched along with Colonic Neoplasms in 2 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohkoshi, M1
Satoh, Y1
Higashi, T1
Nouso, K1
Shiota, T1
Kinugasa, N1
Yoshida, K1
Uematsu, S1
Nakatsukasa, H1
Nishimura, Y1
Tsuji, T1

Reviews

1 review available for camostat and Colonic Neoplasms

ArticleYear
[Protease inhibitors as anticancer chemotherapy--experimental and clinical studies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:4

    Topics: Adenocarcinoma; Animals; Carcinoma, Lewis Lung; Carcinoma, Squamous Cell; Cell Division; Colonic Neo

1995

Other Studies

1 other study available for camostat and Colonic Neoplasms

ArticleYear
Cathepsin B in the growth of colorectal cancer: suppressive effect of leupeptin on the growth of DMH-induced rat colon neoplasm.
    Acta medica Okayama, 1996, Volume: 50, Issue:6

    Topics: 1,2-Dimethylhydrazine; Animals; Carcinogens; Cathepsin B; Colonic Neoplasms; Dimethylhydrazines; Est

1996